By using peptide-based strategies to inhibit anti-apoptotic proteins like BCL-2, programmed mobile Dying can be induced in cancer cells, finally leading to their demise. These focused methodologies show encouraging brings about augmenting the usefulness of most cancers therapy and boosting patient outcomes. Clinical trials and preclinical studie